ifosfamide has been researched along with Waldenstrom Macroglobulinemia in 1 studies
Waldenstrom Macroglobulinemia: A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tournamille, JF | 1 |
| Rigal-Huguet, F | 1 |
| Pathak, A | 1 |
| Montastruc, JL | 1 |
| Lapeyre-Mestre, M | 1 |
1 other study available for ifosfamide and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
[Cardiac effects of cytokines produced after rituximab infusion].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2005 |